ClinConnect ClinConnect Logo
Search / Trial NCT07015788

Open -Label,Cross Over Trail Evaluating the Glycemic Impact of Peach Varieties in Healthy Adullts

Launched by REHMAN MEDICAL INSTITUTE - RMI · Jun 3, 2025

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Glycemic Index Glycemic Load

ClinConnect Summary

This clinical trial is looking at how different types of peaches affect blood sugar levels in healthy adults. Although peaches are generally considered good fruits for managing blood sugar, there can be differences in how different varieties impact blood glucose due to their sugar content and ripeness. By studying these different peach types, the researchers hope to provide better advice on which peaches are best for people who need to manage their blood sugar.

To be part of this study, participants need to be healthy adults aged 18 to 50 years, with a body mass index (BMI) in the normal range and normal fasting blood sugar levels. Those who have diabetes, metabolic issues, or allergies to peaches, among other factors, will not be eligible. Participants can expect to taste various peach varieties and share their experiences, helping researchers understand which peaches might be the best for keeping blood sugar levels stable. Please note that this trial is not yet recruiting participants.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:• Healthy male and female adults aged 18-50 years
  • BMI between 18.5-24.9 kg/m²
  • Normal fasting blood glucose (\<100 mg/dL)
  • Willingness to adhere to the study protocol Exclusion Criteria:• Diagnosed diabetes, metabolic syndrome, or any glucose metabolism disorder
  • Use of medications or supplements that affect glucose levels
  • Allergy to peaches or intolerance to test/reference foods
  • Pregnant or breastfeeding women
  • Smoking or use of recreational drugs

About Rehman Medical Institute Rmi

Rehman Medical Institute (RMI) is a leading healthcare organization dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and scientific integrity, RMI employs state-of-the-art facilities and a multidisciplinary team of experienced professionals to conduct a diverse range of clinical studies. The institute prioritizes ethical standards and patient safety, ensuring that all research activities align with regulatory guidelines and best practices. Through its collaborative approach and focus on cutting-edge therapies, RMI aims to contribute to the global body of medical knowledge and enhance treatment options for various health conditions.

Locations

Peshawar, Kp, Pakistan

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported